Search by Drug Name or NDC

    NDC 67877-0197-10 Amlodipine Besylate 2.5 mg/1 Details

    Amlodipine Besylate 2.5 mg/1

    Amlodipine Besylate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is AMLODIPINE BESYLATE.

    Product Information

    NDC 67877-0197
    Product ID 67877-197_e2555e66-d1b9-4ce3-80ef-9214e159a3aa
    Associated GPIs 34000003100320
    GCN Sequence Number 016925
    GCN Sequence Number Description amlodipine besylate TABLET 2.5 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02681
    HICL Sequence Number 006494
    HICL Sequence Number Description AMLODIPINE BESYLATE
    Brand/Generic Generic
    Proprietary Name Amlodipine Besylate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine besylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name AMLODIPINE BESYLATE
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078925
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0197-10 (67877019710)

    NDC Package Code 67877-197-10
    Billing NDC 67877019710
    Package 1000 TABLET in 1 BOTTLE (67877-197-10)
    Marketing Start Date 2010-10-20
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.0159
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description AMLODIPINE BESYLATE 2.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 3f4703c0-0b9e-41a0-8b70-da26683d9ed2 Details

    Revised: 6/2022